Andrew Vernon
- Infectious Diseases top 1%
- Epidemiology top 5%
- Surgery top 10%
- Molecular Biology
- Pharmacology top 10%
- Co-authors
- Awal KhanWilliam J. BurmanDebra BenatorLorna BozemanRichard E. ChaissonC. Robert HorsburghJ GrossetRichard O’Brien
- Topics
- Tuberculosis Research and Epidemiology (9 papers)Cancer therapeutics and mechanisms (3 papers)Pneumocystis jirovecii pneumonia detection and treatment (3 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Andrew Vernon
12 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Infectious Diseases 1.1k
- Epidemiology 859
- Surgery 501
- Molecular Biology 147
- Pharmacology 100
Countries citing papers authored by Andrew Vernon
This map shows the geographic impact of Andrew Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Vernon more than expected).
Fields of papers citing papers by Andrew Vernon
This network shows the impact of papers produced by Andrew Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Vernon. The network helps show where Andrew Vernon may publish in the future.
Co-authorship network of co-authors of Andrew Vernon
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Vernon. A scholar is included among the top collaborators of Andrew Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Vernon. Andrew Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 37 | |
| 3 | The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse. | 37 |
| 4 | 137 | |
| 5 | 242 | |
| 6 | 297 | |
| 7 | 118 | |
| 8 | 61 | |
| 9 | 26 | |
| 10 | 227 | |
| 11 | 20 | |
| 12 | 4 |
About Andrew Vernon
Andrew Vernon is a scholar working on Infectious Diseases, Epidemiology and Hepatology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Cancer therapeutics and mechanisms (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Epidemiology (859 citations) and Molecular Medicine (70 citations). Andrew Vernon has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Awal Khan, William J. Burman, Debra Benator, Lorna Bozeman, Richard E. Chaisson, C. Robert Horsburgh, J Grosset, Richard O’Brien, William R. Bishai and Eric L. Nuermberger. Their work appears in journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.